Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Shimoyama
Nuclear Accumulation of P53 Correlates Significantly With Clinical Features and Inversely With the Expression of the Cyclin-Dependent Kinase Inhibitor P21WAF1/Cip1 in Pancreatic Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Interleukin-6 Dependent Induction of the Cyclin Dependent Kinase Inhibitor P21WAF1/Cip1 Is Lost During Progression of Human Malignant Melanoma
Oncogene
Cancer Research
Genetics
Molecular Biology
KLF2 Inhibits Jurkat T Leukemia Cell Growth via Upregulation of Cyclin-Dependent Kinase Inhibitor P21WAF1/Cip1
Oncogene
Cancer Research
Genetics
Molecular Biology
HDAC4 Represses P21WAF1/Cip1 Expression in Human Cancer Cells Through a Sp1-Dependent, P53-Independent Mechanism
Oncogene
Cancer Research
Genetics
Molecular Biology
Cyclin-Dependent Kinase Inhibitor, P21Waf1, Regulates Vascular Smooth Muscle Cell Hypertrophy
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
IL-20; IL-20 Receptor-Α (IL20R1; IL20RA); Cyclin-Dependent Kinase Inhibitor 1A (P21, Cip1) (CDKN1A; CIP1)
Science-Business eXchange
Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis
Clinical Cancer Research
Cancer Research
Oncology
Functional Interaction of STAT3 Transcription Factor With the Cell Cycle Inhibitor P21WAF1/Cip1/Sdi1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Expression and Prognostic Significance of Cyclin‑dependent Kinase Inhibitor 1A in Patients With Resected Gastric Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
A Phase I Clinical Trial of FOLFIRI in Combination With the Pan-Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
